Experienced ICAO English Language Proficiency Instructor for pilots and ATCOs and conference interpreter who is passionate about facilitating effective communication within aviation-related businesses ...
In December 2025, Indonesia quietly abandoned plans to close the Cirebon-1 coal power plant. This was no ordinary power plant. Cirebon-1 was supposed to be the centrepiece of a US$21.4 billion ...
In December 2025, Indonesia quietly abandoned plans to close the Cirebon-1 coal power plant. This was no ordinary power plant. Cirebon-1 was supposed to be the centerpiece of a US$21.4 billion ...
Relay Therapeutics’ R&D chief remains convinced the biotech’s PI3Kα inhibitor will carve out its own niche after reporting a slice of phase 2 data in patients with a type of blood vessel disorder. The ...
Showing a significant efficacy signal in a phase II trial, Relay Therapeutics Inc.’s zovegalisib (RLY-2608) achieved a 60% volumetric response – more than double than expected – in patients with ...
The Penn Relays return in 2026, showcasing some of the top athletes in the world. Here's what you need to know about the annual track and field competition from April 23-25. Here's more on the event, ...
SAN DIEGO, April 23, 2026 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma, Connect or the Company), a clinical-stage biopharmaceutical company focused on ...
We watched the sun go down in Islamabad and then come up again as these marathon talks went on. To end without a deal marks a fundamental blow to nascent hopes of finding an off-ramp to this crisis.
Nearly a decade after it was first discussed, the Mount Prospect pedestrian bridge connecting Meadows and Melas parks is closer to construction. Public Works Director Sean Dorsey said the Illinois ...
ALBUQUERQUE, N.M. (KRQE) – Months after the feds dealt Albuquerque a big blow, pulling millions of dollars in grant money from the anticipated Rail Trail project, the city said it’s still pushing ...
A Theravance researcher at work. Theravance Biopharma said it is chopping its workforce by 50% and launching a review of strategic alternatives designed to maximize shareholder value, after its sole ...